Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

NCT07186660 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes (T1D)
Glycemic Control for Diabetes Mellitus
Insulin
Ketones
Cardiovascular Health

Interventions

DRUG: CIR-0602K
DRUG: Placebo

Sponsor

University of Virginia